WW International: Menopause Health's Comeback

  • WW International exited bankruptcy with a cleaner balance sheet, slashing $1.15B in debt and relisting on Nasdaq, enabling renewed strategic focus. New leadership and board overhaul signal a pivot to integrated women's health, especially menopause care, leveraging medical expertise and clinical credibility. The menopause-focused program, blending GLP-1 drugs, coaching, and community support, targets a large, underserved market and could drive future growth.